| Basics |
|
Cogent Biosciences, Inc.
|
| IPO Date: |
March 26, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.95B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.29 | 3.18%
|
| Avg Daily Range (30 D): |
$0.78 | 2.66%
|
| Avg Daily Range (90 D): |
$0.47 | 2.46%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.66M |
| Avg Daily Volume (30 D): |
3.53M |
| Avg Daily Volume (90 D): |
2.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
105 |
| Avg Trade Size (Sh.) (30 D): |
87 |
| Avg Trade Size (Sh.) (90 D): |
86 |
| Institutional Trades |
| Total Inst.Trades: |
2,171 |
| Avg Inst. Trade: |
$1.78M |
| Avg Inst. Trade (30 D): |
$2.31M |
| Avg Inst. Trade (90 D): |
$2.34M |
| Avg Inst. Trade Volume: |
.16M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.15M |
| Avg Closing Trade (30 D): |
$9.23M |
| Avg Closing Trade (90 D): |
$5.33M |
| Avg Closing Volume: |
199.27K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-2.05
|
$-.5
|
$-.53
|
|
Diluted EPS
|
$-2.05
|
$-.5
|
$-.53
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -294.37M
|
$ -80.93M
|
$ -73.53M
|
|
Operating Income / Loss
|
$ -307.6M
|
$ -83.36M
|
$ -75.58M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 28.59M
|
$ -1.97M
|
$ 1.6M
|
|
PE Ratio
|
|
|
|
|
|
|